CACI International (CACI) director gains 84 shares from RSU vesting
Rhea-AI Filing Summary
CACI International director Stanton D. Sloane reported the vesting of 84 Restricted Stock Units (RSUs) into 84 shares of CACI common stock on January 14, 2026, at an exercise price of $0 per share. After this transaction, he beneficially owned 943 shares of CACI common stock and 254 RSUs directly.
These RSUs are part of a 338-unit grant awarded on October 17, 2025, with a scheduled vesting of 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did CACI (CACI) report for Stanton D. Sloane?
Director Stanton D. Sloane reported the vesting and conversion of 84 Restricted Stock Units into 84 shares of CACI common stock on January 14, 2026.
How many CACI common shares does Stanton D. Sloane own after this Form 4?
Following the reported transaction, Stanton D. Sloane beneficially owned 943 shares of CACI common stock directly.
How many Restricted Stock Units does Stanton D. Sloane hold after the transaction?
After the January 14, 2026 vesting, Stanton D. Sloane held 254 Restricted Stock Units directly.
What is the vesting schedule of Stanton D. Sloane’s 338 CACI RSUs?
The 338 RSUs granted on October 17, 2025 vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
What was the transaction code used in Stanton D. Sloane’s CACI Form 4?
The transaction was reported with code M, indicating an exercise or conversion of derivative securities (in this case, RSUs) into CACI common stock.
Is Stanton D. Sloane a director, officer, or major shareholder of CACI?
Stanton D. Sloane is reported as a director of CACI International Inc. and is not listed as an officer or 10% owner in this filing.